Clinical Trial Update: A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study in healthy subjects to evaluate the pharmacokinetic interaction between GSK1292263 and the statins rosuvastatin and simvastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK1292263
• Rosuvastatin (rosuvastatin)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED